Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies

被引:30
作者
Liechti, Fabian D. [1 ]
Grandgirard, Denis [1 ]
Leib, Stephen L. [1 ,2 ]
机构
[1] Univ Bern, Inst Infect Dis, Neuroinfect Lab, CH-3010 Bern, Switzerland
[2] Swiss Fed Off Civil Protect, Div Biol, Spiez Lab, CH-3700 Spiez, Switzerland
基金
瑞士国家科学基金会;
关键词
animal model; bacterial meningitis; brain injury; dentate gyrus; neurogenesis; neuroinfection; neuroinflammation; Streptococcus pneumoniae; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; NONBACTERIOLYTIC ANTIBIOTIC DAPTOMYCIN; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; AGGRAVATES HIPPOCAMPAL APOPTOSIS; STAPHYLOCOCCUS-AUREUS MENINGITIS; INFLUENZAE TYPE-B; CEREBROSPINAL-FLUID; STREPTOCOCCUS-PNEUMONIAE; DENTATE GYRUS;
D O I
10.2217/fmb.15.43
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacterial meningitis is associated with high mortality and morbidity rates. Bacterial components induce an overshooting inflammatory reaction, eventually leading to brain damage. Pathological correlates of neurofunctional deficits include cortical necrosis, damage of the inner ear and hippocampal apoptosis. The hippocampal dentate gyrus is important for memory acquisition and harbors a neuronal stem cell niche, thus being potentially well equipped for regeneration. Adjuvant therapies aimed at decreasing the inflammatory reaction, for example, dexamethasone, and those protecting the brain from injury have been evaluated in animal models of the disease. They include nonbacteriolytic antibiotics (e.g., daptomycin), metalloproteinase inhibitors and modulators of the immunological response, for example, granulocyte colony-stimulating factor. Increasing research interest has recently been focused on interventions aimed at supporting regenerative processes.
引用
收藏
页码:1195 / 1213
页数:19
相关论文
共 50 条
[1]   Bacterial meningitis: an update of new treatment options [J].
Nau, Roland ;
Djukic, Marija ;
Spreer, Annette ;
Ribes, Sandra ;
Eiffert, Helmut .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (11) :1401-1423
[2]   Bacterial meningitis: current therapy and possible future treatment options [J].
Woehrl, Bianca ;
Klein, Matthias ;
Grandgirard, Denis ;
Koedel, Uwe ;
Leib, Stephen .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) :1053-1065
[3]   Bacterial meningitis: new treatment options to reduce the risk of brain damage [J].
Principi, Nicola ;
Esposito, Susanna .
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (01) :97-105
[4]   The Role of Microglia in Bacterial Meningitis: Inflammatory Response, Experimental Models and New Neuroprotective Therapeutic Strategies [J].
Thorsdottir, Sigrun ;
Henriques-Normark, Birgitta ;
Iovino, Federico .
FRONTIERS IN MICROBIOLOGY, 2019, 10
[5]   New advances in the pathogenesis and pathophysiology of bacterial meningitis [J].
Barnett R. Nathan ;
W. Michael Scheld .
Current Infectious Disease Reports, 2000, 2 (4) :332-336
[6]   Role of circadian rhythms in pathogenesis of acute CNS injuries: Insights from experimental studies [J].
Hetman, Michal ;
Slomnicki, Lukasz P. ;
Hodges, Emily R. ;
Ohri, Sujata Saraswat ;
Whittemore, Scott R. .
EXPERIMENTAL NEUROLOGY, 2022, 353
[7]   NEW TREATMENT STRATEGIES FOR BACTERIAL-MENINGITIS [J].
ROOS, KL .
CLINICAL NEUROPHARMACOLOGY, 1993, 16 (05) :373-386
[8]   Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis [J].
Lee, H ;
Song, JH ;
Kim, SW ;
Oh, WS ;
Jung, SI ;
Kiem, S ;
Peck, KR ;
Lee, NY .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (03) :307-310
[9]   What's new in the treatment of bacterial meningitis in childhood? [J].
Sarlangue, J. ;
Castella, C. ;
Lehours, P. .
ARCHIVES DE PEDIATRIE, 2009, 16 (06) :787-789
[10]   New Insights in the Prevention, Diagnosis, and Treatment of Cryptococcal Meningitis [J].
Jackson, Arthur ;
van der Horst, Charles .
CURRENT HIV/AIDS REPORTS, 2012, 9 (03) :267-277